BMRN vs OPAL · P/E 40, rev $2.85B vs P/E 26, rev $349.0M
Biomarin Pharmaceutical Inc (BMRN) versus OPAL Fuels Inc (OPAL) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
OPAL Fuels Inc (OPAL) is a utilities - regulated gas company listed on NASDAQ.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported OPAL revenue for 2025-12-31 was $349.0M. Net income was $36.4M. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. OPAL currently screens at market cap $318.1M and trailing P/E 26.0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. OPAL currently screens at market cap $318.1M and trailing P/E 26.0.
Not investment advice. Open the BMRN and OPAL stock pages for the full models.
Not investment advice.